- Home
- CI
as 11-20-2024 4:00pm EST
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 18 million US medical members covered as of December 2023.
| Founded: | 1792 | Country: | United States |
| Employees: | N/A | City: | BLOOMFIELD |
| Market Cap: | 88.0B | IPO Year: | N/A |
| Target Price: | $393.76 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 10.57 | EPS Growth: | -40.55 |
| 52 Week Low/High: | $253.95 - $370.83 | Next Earning Date: | 10-31-2024 |
| Revenue: | $229,747,000,000 | Revenue Growth: | 21.00% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 3.30% |
Latest The Cigna Group News
CI Breaking Stock News: Dive into CI Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley
MT Newswires
2 days ago
UnitedHealth, CVS, Cigna Units Sue to Block FTC Case Against Drug Middlemen
TipRanks
2 days ago
Cigna price target raised to $370 from $355 at Wells Fargo
MT Newswires
3 days ago
Wells Fargo Adjusts Price Target on Cigna to $370 From $355, Maintains Equalweight Rating
Healthcare Dive
3 days ago
Offering health insurance is becoming less lucrative
MT Newswires
7 days ago
Ameriprise Initiates Cigna at Buy
Argus Research
8 days ago
CI: Raising target price to $374.00
Zacks
9 days ago
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips
Compare CI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CI The Cigna Group - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.